GVHD
Clinical trials for GVHD explained in plain language.
Never miss a new study
Get alerted when new GVHD trials appear
Sign up with your email to follow new studies for GVHD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Blood cancer transplant study tests blood pressure drug for immune complication
Disease control TerminatedThis study looked at whether the blood pressure drug telmisartan could prevent a serious immune reaction called graft-versus-host disease (GVHD) in people receiving a stem cell transplant for blood cancers. About 32 participants were planned, but the study was stopped early. The …
Matched conditions: GVHD
Phase: NA • Sponsor: Hackensack Meridian Health • Aim: Disease control
Last updated May 01, 2026 15:27 UTC
-
New drug aimed at treating severe gut complication after stem cell transplant
Disease control TerminatedThis study tested a drug called apraglutide in 31 people who had severe gut problems after a stem cell transplant that did not get better with steroids. The goal was to see if the drug is safe and helps control the disease. The trial was stopped early, so results are limited.
Matched conditions: GVHD
Phase: PHASE2 • Sponsor: VectivBio AG • Aim: Disease control
Last updated May 01, 2026 15:26 UTC